IBDEI076 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9384,0)
 ;;=V10.04^^69^664^70
 ;;^UTILITY(U,$J,358.3,9384,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9384,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,9384,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,9384,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,9385,0)
 ;;=V10.47^^69^664^71
 ;;^UTILITY(U,$J,358.3,9385,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9385,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,9385,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,9385,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,9386,0)
 ;;=V10.83^^69^664^69
 ;;^UTILITY(U,$J,358.3,9386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9386,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,9386,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,9386,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,9387,0)
 ;;=285.22^^69^664^9
 ;;^UTILITY(U,$J,358.3,9387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9387,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,9387,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,9387,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,9388,0)
 ;;=285.21^^69^664^10
 ;;^UTILITY(U,$J,358.3,9388,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9388,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,9388,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,9388,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,9389,0)
 ;;=285.29^^69^664^11
 ;;^UTILITY(U,$J,358.3,9389,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9389,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,9389,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,9389,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,9390,0)
 ;;=284.9^^69^664^13
 ;;^UTILITY(U,$J,358.3,9390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9390,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,9390,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,9390,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,9391,0)
 ;;=282.61^^69^664^75
 ;;^UTILITY(U,$J,358.3,9391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9391,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,9391,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,9391,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,9392,0)
 ;;=282.7^^69^664^74
 ;;^UTILITY(U,$J,358.3,9392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9392,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,9392,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,9392,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,9393,0)
 ;;=283.9^^69^664^77
 ;;^UTILITY(U,$J,358.3,9393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9393,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,9393,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,9393,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,9394,0)
 ;;=283.0^^69^664^78
 ;;^UTILITY(U,$J,358.3,9394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9394,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,9394,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,9394,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,9395,0)
 ;;=282.9^^69^664^76
 ;;^UTILITY(U,$J,358.3,9395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9395,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,9395,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,9395,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,9396,0)
 ;;=283.19^^69^664^79
 ;;^UTILITY(U,$J,358.3,9396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9396,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,9396,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,9396,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,9397,0)
 ;;=280.9^^69^664^83
 ;;^UTILITY(U,$J,358.3,9397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9397,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,9397,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,9397,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,9398,0)
 ;;=285.1^^69^664^81
 ;;^UTILITY(U,$J,358.3,9398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9398,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,9398,1,5,0)
 ;;=5^Iron Defic Anemia d/t Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,9398,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,9399,0)
 ;;=280.0^^69^664^82
 ;;^UTILITY(U,$J,358.3,9399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9399,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,9399,1,5,0)
 ;;=5^Iron Defic Anemia d/t Chr Blood Loss
 ;;^UTILITY(U,$J,358.3,9399,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,9400,0)
 ;;=281.9^^69^664^101
 ;;^UTILITY(U,$J,358.3,9400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9400,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,9400,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,9400,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,9401,0)
 ;;=281.0^^69^664^121
 ;;^UTILITY(U,$J,358.3,9401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9401,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,9401,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,9401,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,9402,0)
 ;;=282.60^^69^664^108
 ;;^UTILITY(U,$J,358.3,9402,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9402,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,9402,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,9402,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,9403,0)
 ;;=282.62^^69^664^109
 ;;^UTILITY(U,$J,358.3,9403,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9403,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,9403,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,9403,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,9404,0)
 ;;=281.1^^69^664^122
 ;;^UTILITY(U,$J,358.3,9404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9404,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,9404,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,9404,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,9405,0)
 ;;=286.7^^69^664^51
 ;;^UTILITY(U,$J,358.3,9405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9405,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,9405,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,9405,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,9406,0)
 ;;=289.9^^69^664^118
 ;;^UTILITY(U,$J,358.3,9406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9406,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,9406,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,9406,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,9407,0)
 ;;=451.9^^69^664^119
 ;;^UTILITY(U,$J,358.3,9407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9407,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,9407,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,9407,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,9408,0)
 ;;=446.6^^69^664^120
 ;;^UTILITY(U,$J,358.3,9408,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9408,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,9408,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(TTP)
 ;;^UTILITY(U,$J,358.3,9408,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,9409,0)
 ;;=286.4^^69^664^123
 ;;^UTILITY(U,$J,358.3,9409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9409,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,9409,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,9409,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,9410,0)
 ;;=204.00^^69^664^2
 ;;^UTILITY(U,$J,358.3,9410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9410,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,9410,1,5,0)
 ;;=5^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,9410,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,9411,0)
 ;;=204.01^^69^664^1
 ;;^UTILITY(U,$J,358.3,9411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9411,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,9411,1,5,0)
 ;;=5^ALL in Remission
 ;;^UTILITY(U,$J,358.3,9411,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,9412,0)
 ;;=204.10^^69^664^26
 ;;^UTILITY(U,$J,358.3,9412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9412,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,9412,1,5,0)
 ;;=5^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,9412,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,9413,0)
 ;;=204.11^^69^664^24
 ;;^UTILITY(U,$J,358.3,9413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9413,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,9413,1,5,0)
 ;;=5^CLL in Remission
 ;;^UTILITY(U,$J,358.3,9413,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,9414,0)
 ;;=202.41^^69^664^73
 ;;^UTILITY(U,$J,358.3,9414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9414,1,4,0)
 ;;=4^202.41
 ;;^UTILITY(U,$J,358.3,9414,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspec Site
 ;;^UTILITY(U,$J,358.3,9414,2)
 ;;=^267472
 ;;^UTILITY(U,$J,358.3,9415,0)
 ;;=201.90^^69^664^80
 ;;^UTILITY(U,$J,358.3,9415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9415,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,9415,1,5,0)
 ;;=5^Hodgkin's Lymphoma,Unspec Type & Site
 ;;^UTILITY(U,$J,358.3,9415,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,9416,0)
 ;;=785.6^^69^664^86
 ;;^UTILITY(U,$J,358.3,9416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9416,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,9416,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,9416,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,9417,0)
 ;;=200.20^^69^664^89
 ;;^UTILITY(U,$J,358.3,9417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9417,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,9417,1,5,0)
 ;;=5^Lymphoma,Burkett's,Unspecified Sites
 ;;^UTILITY(U,$J,358.3,9417,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,9418,0)
 ;;=202.00^^69^664^88
 ;;^UTILITY(U,$J,358.3,9418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9418,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,9418,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,9418,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,9419,0)
 ;;=200.10^^69^664^87
 ;;^UTILITY(U,$J,358.3,9419,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9419,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,9419,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,9419,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,9420,0)
 ;;=273.3^^69^664^90
 ;;^UTILITY(U,$J,358.3,9420,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9420,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,9420,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,9420,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,9421,0)
 ;;=203.00^^69^664^99
 ;;^UTILITY(U,$J,358.3,9421,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9421,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,9421,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
